The new EANM paediatric dosage card: additional notes with respect to F-18

  • M. LassmannEmail author
  • L. Biassoni
  • M. Monsieurs
  • C. Franzius
  • EANM Dosimetry and Paediatrics Committees
Short Communication



The previously published European Association of Nuclear Medicine (EANM) paediatric dosage card recommends 70 MBq F-18 or F-18 Fluoro-2-Deoxyglucose (F-18-FDG) as the “minimum recommended activity”.


Two recent publications demonstrate that when utilising F-18-labelled radiopharmaceuticals the administration of lower activities for small children is possible without losing image quality.


In the light of these findings the EANM dosimetry and paediatrics committee have decided to reduce the value for the “minimum recommended activity” for both F-18 and F-18-FDG to 26 MBq for 2D- and 14 MBq for 3D-acquisitions.


Paediatrics Dosimetry Diagnostic procedures Nuclear medicine Radionuclide 




The European Association has written and approved guidelines to promote the use of nuclear medicine procedures with high quality. These general recommendations cannot be applied to all patients in all practice settings. The guidelines should not be deemed inclusive of all proper procedures and exclusive of other procedures reasonably directed to obtaining the same results. The spectrum of patients seen in a specialised practice setting may be different than a spectrum usually seen in a more general setting. The appropriateness of a procedure will depend in part on the prevalence of disease in the patient population. In addition resources available to care for patients may vary greatly from one European country or one medical facility to another. For these reasons, guidelines cannot be rigidly applied.


  1. 1.
    Holm S, Borgwardt L, Loft A, Graff J, Law I, Hojgaard L. Paediatric doses—a critical appraisal of the EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2007;34(11):1713–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Warbey VS, Schleyer PJ, Barrington SF, O’Doherty MJ. The new EANM paediatric dosage card—does it conform to ALARA for PET/CT. Eur J Nucl Med Mol Imaging. 2007;34(11):1881–82.PubMedCrossRefGoogle Scholar
  3. 3.
    Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2007;34(5):796–8PubMedCrossRefGoogle Scholar
  4. 4.
    ICRP Publication 60. 1990 Recommendations of the ICRP. Annals of ICRP 1992 21:1–3; Pergamon Press, Oxford.Google Scholar
  5. 5.
    ICRP Publication 80. Radiation dose to patients from radiopharmaceuticals. Annals of the ICRP 1999 28; Pergamon Press, Oxford.Google Scholar
  6. 6.
    Bartenstein P, Asenbaum S, Catafau A, Halldin C, Pilowski L, Pupi A, et al. Brain imaging using [18F]FDG. 2001.
  7. 7.
    Schober O, Heindel W. PET-CT. RRR (Referenz Reihe Radiologie) Georg Thieme Verlag Stuttgart; 2008, p 80.Google Scholar
  8. 8.
    Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J, Gwillst J. A radiopharmaceutical schedule for imaging in paediatrics. Eur J Nucl Med. 1990;17:127–29.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • M. Lassmann
    • 1
    Email author
  • L. Biassoni
    • 2
  • M. Monsieurs
    • 3
  • C. Franzius
    • 4
  • EANM Dosimetry and Paediatrics Committees
  1. 1.Klinik und Poliklinik für Nuklearmedizin der Universität WürzburgWürzburgGermany
  2. 2.Department of RadiologyGreat Ormond Street Hospital for ChildrenLondonUK
  3. 3.Health and Safety Department, Health PhysicsGhent UniversityGhentBelgium
  4. 4.MR-and PET/CT-centre Bremen-MitteBremenGermany

Personalised recommendations